Related Experiment Video
Updated: Apr 15, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
Isolation, Cultivation, and Transient Transfection of Primary Human T Cells to Generate Chimeric Antigen Receptor
Elisabeth A Lehner1, Sanna M Riedl2, Florian Haberl2
1Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna; elisabeth.a.lehner@meduniwien.ac.at.
Abstract:
To assess the efficacy and potency of chimeric antigen receptor (CAR) T cells, it is essential to isolate, activate, expand, characterize, and genetically engineer primary human T cells. Compared to common T cell lines, primary cells can provide a more realistic model system, since they are highly variable, capable of T cell-mediated killing, and able to differentiate. Here, we provide a step-by-step protocol for all essential steps for the cultivation of primary T cells, including their isolation from blood products, activation, in vitro expansion, and transient transfection. We describe differences in expansion kinetics and differentiation of primary T cells upon activation with two different reagents and provide an antibody panel for flow cytometric analysis of T cell phenotype and activation state. We offer detailed instructions for electroporation of human T cells with mRNA encoding a CAR and assessing CAR expression kinetics over time. This protocol provides recommendations on ideal timepoints for downstream potency and efficacy assays of CAR T cells and the influence of different amounts of mRNA on signal intensity. Given the transient nature of this method, it provides a rapid and easy-to-implement possibility to test and compare many CAR constructs in parallel.
More Related Videos
11:21Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs
Published on: September 10, 2017
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025